(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.05%) $82.59
(1.82%) $2.07
(-0.68%) $2 341.70
(-1.52%) $27.24
(-0.15%) $960.10
(0.18%) $0.934
(0.28%) $11.01
(0.14%) $0.797
(0.01%) $93.31
0.00% $ 18.00
Live Chart Being Loaded With Signals
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others...
Stats | |
---|---|
Volumen de hoy | 465.00 |
Volumen promedio | 493 725 |
Capitalización de mercado | 0.00 |
Last Dividend | $0.108 ( 2022-03-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.819 (4.55%) |
Volumen Correlación
Olympus Corporation Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Olympus Corporation Correlación - Moneda/Commodity
Olympus Corporation Finanzas
Annual | 2022 |
Ingresos: | $868.87B |
Beneficio Bruto: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2022 |
Ingresos: | $868.87B |
Beneficio Bruto: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2021 |
Ingresos: | $730.54B |
Beneficio Bruto: | $459.53B (62.90 %) |
EPS: | $10.05 |
FY | 2020 |
Ingresos: | $797.41B |
Beneficio Bruto: | $499.57B (62.65 %) |
EPS: | $39.37 |
Financial Reports:
No articles found.
Olympus Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0156 | 2003-03-26 |
Last Dividend | $0.108 | 2022-03-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | $1.329 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.62 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.84 | |
Div. Directional Score | 7.24 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SCGLY | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
FSUGY | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
AGESY | Ex Dividend Junior | 2023-10-25 | Annually | 0 | 0.00% | |
YATRF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
MONDY | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
CNLTP | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
STBI | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
HKXCY | Ex Dividend Knight | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
ASBFY | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% | |
OLCLF | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.173 | 1.500 | 6.54 | 9.81 | [0 - 0.5] |
returnOnAssetsTTM | 0.0558 | 1.200 | 8.14 | 9.77 | [0 - 0.3] |
returnOnEquityTTM | 0.125 | 1.500 | 9.73 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.83 | 3.86 | [1 - 3] |
quickRatioTTM | 0.544 | 0.800 | -1.503 | -1.203 | [0.8 - 2.5] |
cashRatioTTM | 0.495 | 1.500 | 8.36 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.253 | -1.500 | 5.78 | -8.67 | [0 - 0.6] |
interestCoverageTTM | 35.39 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.584 | -1.500 | 7.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.686 | 1.000 | 1.908 | 1.908 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.236 | 1.000 | 7.28 | 7.28 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.232 | 1.000 | 9.82 | 9.82 | [0.2 - 2] |
assetTurnoverTTM | 0.323 | 0.800 | -1.183 | -0.946 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.41 | 1.000 | 5.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.125 | 2.50 | 9.82 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.000360 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.182 | 1.000 | 7.95 | 0 | [0.1 - 0.5] |
Total Score | 3.84 |
Olympus Corporation
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico